Throughout the last decade, interventions to engineer the immune system called
immunotherapy have revolutionized the fields of oncology and autoimmune disease …

Cancer immunotherapy has revolutionized clinical cancer treatments by taking advantage of
the immune system to selectively and effectively target and kill cancer cells. However …

Surgical removal of tumor tissue remains the primary clinical approach for addressing breast
cancer; however, complete tumor excision is challenging, and the remaining tumor cells can …

Hydrophobic active pharmaceutical ingredients (APIs) are ubiquitous in the drug
development pipeline, but their poor bioavailability often prevents their translation into drug …

Subcutaneous route of administration presents a promising solution to address the
challenges encountered with other drug delivery routes. Injectable hydrogel formulations …

In recent decades, subcutaneous (SC) administration of monoclonal antibodies (mAbs) has
emerged as a promising alternative to intravenous delivery in oncology, offering comparable …

Biopharmaceutical drugs, including proteins, peptides, and antibodies, are renowned for
their high specificity and efficacy, fundamentally transforming disease treatment paradigms …

Pulmonary delivery of protein therapeutics poses significant challenges that have not been
well addressed in the research literature or practice. In fact, there is currently only one …

The fast pace of breakthroughs in cancer immunotherapy, combined with the new paradigm
of moving toward high-concentration dosages and combinatorial treatments, is generating …

Industry update covering March 2023 | Therapeutic Delivery Future Science Logo Search
This Journal Anywhere Quick Search in Journals Enter words / phrases / DOI / ISBN …